Results 121 to 130 of about 31,793 (243)

Is Ticagrelor the Antiplatelet Therapy Panacea? [PDF]

, 2010
Amber L. Beitelshees
openalex   +1 more source

Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target in Russia as a whole and Russian regions in 2023-2025

, 2023
М. В. Журавлева, S. К. Zyryanov, Ф. Н. Палеев, A. N. Yakovlev, Yu. V. Gagarina, T. V. Marin   +5 more
openalex   +2 more sources

Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular Events [PDF]

, 2023
Rachel A. Myers, Thomas L. Ortel, Alexander Waldrop, MacIntosh Cornwell, Jonathan Newman, Natalie Levy, Tessa J. Barrett, Kelly V. Ruggles, Marcin A. Sowa, Sandeep S. Davé, Geoffrey S. Ginsburg, Jeffrey S. Berger, Deepak Voora   +12 more
openalex   +1 more source

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017 [PDF]

, 2020
Safoura Sheikh Rezaei, Andreas Gleiß, Berthold Reichardt, Michael Wolzt   +3 more
openalex   +1 more source

Ticagrelor inverse agonist activity at the P2Y₁₂ receptor is non‐reversible versus its endogenous agonist adenosine 5´‐diphosphate [PDF]

, 2023
Jawad S. Khalil, Tudor Dimofte, Timothy K. Roberts, M. J. Keith, Kumuthu S. Amaradasa, Matthew S. Hindle, Sukhinder Bancroft, James L. Hutchinson, Khalid M. Naseem, Tom Johnson, Stuart J. Mundell   +10 more
openalex   +1 more source

Corrigendum to ‘Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Korean Male Volunteers’ [PDF]

, 2015
Hae-Sun Jeon, Mi-Jo Kim, Hee‐Youn Choi, Yo-Han Kim, Eun‐Hwa Kim, A-Reum Kim, Hyun-Jung Park, Kyun‐Seop Bae, Hyeong‐Seok Lim   +8 more
openalex   +1 more source

High-dose clopidogrel, prasugrel or ticagrelor: trying to unravel a skein into a ball [PDF]

, 2011
Alessandro Aprile, Raffaella Marzullo, Giuseppe Biondi‐Zoccai, Maria Grazia Modena   +3 more
openalex   +1 more source

Evaluating the Safety and Efficacy of Ticagrelor vs. Clopidogrel Following Percutaneous Coronary Intervention in Chronic Coronary Disease [PDF]

Muhammad Abdur Rauf, Muhammad Ziyad, Nida Mahmood, Habib Ullah, Farooq Ahmad, Ikram Ullah, Syed Muzammil Shah   +6 more
openalex   +1 more source

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [PDF]

, 2014
Steen Husted, Stefan James, Richard G. Bach, Richard C. Becker, Andrzej Budaj, Manuel Heras, Anders Himmelmänn, Jay Horrow, Hugo A. Katus, Riitta Lassila, João Morais, José Carlos Nicolau, Philippe Gabríel Steg, Robert F. Storey, D. Wojdyla, Lars Wallentin, for the PLATO study group   +16 more
openalex   +1 more source

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice [PDF]

, 2021
Liam Mullen, Mohammed N. Meah, Ahmed Elamin, Suneil Aggarwal, Adeel Shahzad, Matthew Shaw, Jaroslav Hasara, Muhammad Rashid, Michael Fisher, Turab Ali, Billal Patel, Wern Yew Ding, Ruth Grainger, Thomas Heseltine, Bilal H. Kirmani, Mohammed Obeidat, Yande Kasolo, Jecko Thatchil, Aleem Khand   +18 more
openalex   +1 more source